Conestoga Capital Advisors LLC 13D and 13G filings for Mesa Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-10 11:55 am Purchase | 2024-12-31 | 13G | Mesa Laboratories, Inc. MLAB | Conestoga Capital Advisors LLC | 618,111 11.380% | 499 (+0.08%) | Filing |
| 2024-01-05 09:48 am Purchase | 2023-12-31 | 13G | Mesa Laboratories, Inc. MLAB | Conestoga Capital Advisors LLC | 617,612 11.450% | 12,495 (+2.06%) | Filing |
| 2023-01-18 09:14 am Sale | 2022-12-31 | 13G | Mesa Laboratories, Inc. MLAB | Conestoga Capital Advisors LLC | 605,117 11.340% | -1,702 (-0.28%) | Filing |
| 2022-11-18 12:20 pm Purchase | 2022-11-18 | 13G | Mesa Laboratories, Inc. MLAB | Conestoga Capital Advisors LLC | 606,819 11.370% | 65,241 (+12.05%) | Filing |
| 2022-01-10 2:12 pm Purchase | 2021-12-31 | 13G | Mesa Laboratories, Inc. MLAB | Conestoga Capital Advisors LLC | 541,578 10.360% | 8,980 (+1.69%) | Filing |
| 2021-01-06 12:18 pm Purchase | 2020-12-31 | 13G | Mesa Laboratories, Inc. MLAB | Conestoga Capital Advisors LLC | 532,598 10.410% | 42,392 (+8.65%) | Filing |